Trial
NCT02420210
Bendamustine, Obinutuzumab, and Dexamethasone in Older Patients With Diffuse Large B-cell Lymphoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
National Cancer Institute (NCI)
Condition
Diffuse Large B-Cell Lymphoma
Intervention
Bendamustine Hydrochloride
Why stopped
Trials was stopped early due to lack of funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-06-06